Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003 : Original article  

Peroxynitrite-PARP-1 pathway in traumatic brain injury in rats

V. Besson, N. Croci, R. Boulu, M. Plotkine, C. Marchand-Verrecchia

Med Sci Monit 2003; 9(1): 3-0 :: ID: 14988

Abstract

Background:Nitric oxide and free radicals contribute to injury elicited by traumatic brain injury (TBI) [1,2]. Peroxynitrite, resulting from the combination of nitric oxide and superoxide anion triggers DNA strand breakage, leading to the activation of poly(ADP-ribose)polymerase-1 (PARP-1) [3]. As excessive activation of this enzyme induces cell death, we examine the implication of peroxynitrite-PARP-1 pathway in the post-traumatic outcomes of focal TBI caused by fluid percussion on rats [4]. Material/Methods:In a first experiment, animals were killed 30 min, 2, 4, 6, 24, 48 and 72h after TBI for immunohistochemistry of a) 3-nitrotyrosine as a footprint of peroxynitrite production and b) poly(ADP-ribose) as a marker of PARP-1 activation. In a second experiment, the effect of 3-aminobenzamide (3-AB), a widely used PARP inhibitor, was investigated on the neurological deficit, the cerebral lesion and the activation of PARP-1. Rats were given 3-AB (10 and 30 mg/kg, i.p.) or its vehicle 30 min before, and 24, 48 and 72h after TBI. Results: Immunohistochemistry showed that 3-nitrotyrosine and poly(ADP-ribose) were present as early as 30 min post-injury, and persisted for 72h. Treatment with 3-AB significantly decreased the neurological deficit, the cerebral lesion and the poly(ADP-ribose) staining induced by TBI. Conclusions: The present study indicates that TBI induces peroxynitrite production associated with PARP-1 activation. Treatment with 3-AB, a PARP inhibitor, decreases the neurological deficit, the cerebral lesion and the PARP-1 activation caused by TBI. Thus, PARP-1 is involved in the pathogenesis of TBI and may be a promising therapeutic target for the treatment of brain trauma.References: 1.Mésenge C et al: J Neurotrauma, 1996; 13: 209-214 2.Mésenge C et al: J Pineal Res, 1998; 25: 41-46 3.Virág L, Szabó C: Pharmacol Rev, 2002; 54: 375-429 4.Toulmond S et al: Brain Res, 1993; 620: 24-31

Keywords: 3-nitrotyrosine, 3-aminobenzamide, neuroprotection, poly(ADP-ribose)polymerase-1, peroxynitrite, traumatic brain injury

Add Comment 0 Comments

Editorial

01 April 2024 : Editorial  

Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug Resistance

Dinah V. Parums

DOI: 10.12659/MSM.944600

Med Sci Monit 2024; 30:e944600

0:00

In Press

05 Mar 2024 : Clinical Research  

Muscular Function Recovery from General Anesthesia in 132 Patients Undergoing Surgery with Acceleromyograph...

Med Sci Monit In Press; DOI: 10.12659/MSM.942780  

05 Mar 2024 : Clinical Research  

Effects of Thermal Insulation on Recovery and Comfort of Patients Undergoing Holmium Laser Lithotripsy

Med Sci Monit In Press; DOI: 10.12659/MSM.942836  

05 Mar 2024 : Clinical Research  

Role of Critical Shoulder Angle in Degenerative Type Rotator Cuff Tears: A Turkish Cohort Study

Med Sci Monit In Press; DOI: 10.12659/MSM.943703  

06 Mar 2024 : Clinical Research  

Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943797  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750